10
Participants
Start Date
May 31, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
March 31, 2026
5-Aminolevulinic acid Hydrochloride (Gliolan®)
Participants will receive a single oral dose of 5-aminolevulinic acid (20 mg/kg) approximately 2 to 4 hours prior to surgery. The goal is to evaluate the feasibility of using fluorescence cystoscopy with blue light to improve tumor detection and visualization during ureteroscopic resection of upper tract urothelial carcinoma.
Henry Ford Hospital, Detroit
Henry Ford Health System
OTHER